Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
?

?

-5.560%
-0.0025
-5.560%
-
 
07:30 / Stuttgart Stock Exchange WKN: 932414 / Name: MedMira / Stock / Healthcare Equipment & Supplies / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Medmira Inc. Stock

Medmira Inc. took a tumble today and lost -€0.003 (-5.560%).

Pros and Cons of Medmira Inc. in the next few years

Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Medmira Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Medmira Inc. -5.560% 18.421% 12.500% -10.891% -43.750% -40.789% -
Theralase Technologies Inc -3.250% -2.381% 5.128% 18.269% -23.125% -40.865% 12.844%
Atossa Genetics Inc 0.150% -1.508% -9.807% -47.508% -32.402% -28.975% -69.271%
Aortech International plc -9.410% -8.500% -2.139% -1.081% -18.304% -83.211% -94.020%

News

Health Canada approves MedMira’s Reveal® Rapid TP Test - Urgent New Tool In The Battle Against Syphilis
Health Canada approves MedMira’s Reveal® Rapid TP Test - Urgent New Tool In The Battle Against Syphilis

Halifax, Nova Scotia, 26 August 2025 – MedMira Inc. (MedMira) (TSXV: MIR) announced today that it has received approval from Health Canada for its Reveal® TP (Syphilis) Antibody Test (Reveal®

MedMira Announces Launch of Clinical Trial for Its Multiplo® TP/HIV Self-Test in Canada
MedMira Announces Launch of Clinical Trial for Its Multiplo® TP/HIV Self-Test in Canada

Halifax, Nova Scotia, July 7, 2025 – MedMira Inc. (MedMira) (TSXV: MIR) and REACH Nexus are excited to announce a clinical trial has officially started earlier than anticipated to evaluate

MedMira Inc. and Lovell Announce Partnership to Increase Access to Reveal(R) G4 HIV-1/2 rapid test for VA, Department of Defense
MedMira Inc. and Lovell Announce Partnership to Increase Access to Reveal(R) G4 HIV-1/2 rapid test for VA, Department of Defense

Halifax, Nova Scotia, 17th of April, 2025 - MedMira Inc. (MedMira) (TSXV: MIR) and Lovell® Government Services announced today that they have partnered to serve federal healthcare systems